Nortem Biogroup (XPAR:MLBIO) Interest Expense : € Mil (TTM As of Dec. 2022)

View and export this data going back to 2023. Start your Free Trial

What is Nortem Biogroup Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Nortem Biogroup's interest expense for the six months ended in Dec. 2022 was € -0.07 Mil. Nortem Biogroup does not have enough years/quarters to calculate its interest expense for the trailing twelve months (TTM) ended in Dec. 2022.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Nortem Biogroup's Operating Income for the six months ended in Dec. 2022 was € 0.63 Mil. Nortem Biogroup's Interest Expense for the six months ended in Dec. 2022 was € -0.07 Mil. Nortem Biogroup's Interest Coverage for the quarter that ended in Dec. 2022 was 9.32. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Nortem Biogroup Interest Expense Historical Data

The historical data trend for Nortem Biogroup's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nortem Biogroup Interest Expense Chart

Nortem Biogroup Annual Data

Trend

Dec21

Dec22

Interest Expense

-0.11

-0.07

Nortem Biogroup Semi-Annual Data
	Dec21	Dec22
Interest Expense	-0.11	-0.07

Nortem Biogroup Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Nortem Biogroup (XPAR:MLBIO) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Nortem Biogroup's Interest Expense for the six months ended in Dec. 2022 was €-0.07 Mil. Its Operating Income for the six months ended in Dec. 2022 was €0.63 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2022 was €3.39 Mil.

Nortem Biogroup's Interest Coverage for the quarter that ended in Dec. 2022 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2022 )	/	Interest Expense (Q: Dec. 2022 )
	=	-1	*	0.634	/	-0.068
	=	9.32

The higher the ratio, the stronger the company's financial strength is.

Nortem Biogroup (XPAR:MLBIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Nortem Biogroup (XPAR:MLBIO) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Calle Alexander Humboldt 12B, Polígono Industrial Salinas de Poniente, El Puerto de Santa María, Cadiz, ESP, 11500

Website

https://www.nortembiogroup.com

Nortem Chem SA is engaged in the research, development, innovation and industrialization in the field of biochemistry and biotechnology, as well as the production and sale of products based on biochemical and/or biotechnological processes. It emerged as a biotechnological company in the field of the food and chemical industry, with maximum environmental awareness, concentrating its research and product development efforts on the development of environmentally friendly alternatives from renewable sources and obtaining its own microorganisms (Aspergillus Niger and Yarrowia lipolytica) with outstanding capabilities from adaptation and selection processes, avoiding the use of genetic modification technologies.

Nortem Biogroup (XPAR:MLBIO) Headlines

No Headlines